Glycemic Index/ Load and Mental Disorders
NCT02362113 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2015-02-12
Summary
A total of 300 adults would be included in the present cross-sectional study. glycemic index (GI) and glycemic load (GL) would be assessed by using a validated self-administered dish-based semi-quantitative food frequency questionnaire. Validated Iranian versions of Hospital Anxiety and Depression Scale and General Health Questionnaire-12 would be used to assess anxiety, depression and psychological distress.
Conditions
- Depression
- Anxiety
- Psychological Distress
Interventions
- OTHER
-
GI/GL
GI and GL would be categorized as tertile. due to cross-sectional design of this study, intervention would not be applicable.
Sponsors & Collaborators
-
Isfahan University of Medical Sciences
lead OTHER
Principal Investigators
-
Peyman Adibi, MD · Integrative Functional Gastroenterology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-12-31
- Primary Completion
- 2015-04-30
- Completion
- 2015-06-30
More Related Trials
-
Lifestyle Intervention for Diabetes and Weight Management in Psychosis
NCT01828931 ·Status: COMPLETED ·Phase: NA
-
Glucose and Lipid Metabolism on Antipsychotic Medication
NCT00515723 ·Status: COMPLETED ·Phase: NA
-
Home-based Intervention With Semaglutide Treatment Of Neuroleptica-Related Prediabetes
NCT05193578 ·Status: COMPLETED ·Phase: PHASE2
-
The Relationship Between COVID-19 Anxiety Level and Emotional Eating in Individuals With Metabolic Syndrome
NCT04912934 ·Status: COMPLETED
-
The Effect of Dulaglutide as an Adjuvant Therapy on Cognitive Function in Bipolar Disorder Patients With Obesity
NCT06331286 ·Status: UNKNOWN ·Phase: NA
-
Heart Rate Variability in Response to Metformin Challenge
NCT02500628 ·Status: COMPLETED ·Phase: PHASE2
-
The Synergistic Effect of Hypoglycemic Index Diet on Refractory Schizophrenia
NCT04302636 ·Status: UNKNOWN ·Phase: NA
-
Evaluating the Effect of the STEP@STAH Semaglutide Protocol on the Physical Health Measures of Atypical Antipsychotic-Treated Patients
NCT06754163 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Metformin Treatment on Cognitive Impairment of Schizophrenia Co-morbid Metabolic Syndrome
NCT03271866 ·Status: UNKNOWN ·Phase: NA
-
Metformin in Co-morbid Diabetes or Prediabetes and Serious Mental Illness
NCT02167620 ·Status: COMPLETED ·Phase: PHASE4
-
The Impact of the Mediterranean Diet on Anthropometric Indices, Lipid Profiles, Energy Metabolism Signaling Proteins and Inflammatory Cytokines in Psychiatric Patients With Metabolic Syndrome
NCT07164014 ·Status: COMPLETED ·Phase: NA
-
Circadian Clocks and Eating Patterns (Cohort)
NCT04642534 ·Status: COMPLETED
-
Green Tea Extract for Obesity of Psychiatric Patients
NCT03548103 ·Status: COMPLETED ·Phase: NA
-
Pioglitazone in Patients With Mood Disorders
NCT01559857 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Lifestyle Interventions and Metformin for the Treatment of Antipsychotic-Induced Weight Gain
NCT00451399 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Antipsychotics on Brain Insulin Action in Females
NCT06251635 ·Status: RECRUITING ·Phase: NA
-
Metformin for Overweight & OBese ChILdren and Adolescents With BDS Treated With SGAs
NCT02515773 ·Status: COMPLETED ·Phase: PHASE4
-
Monitoring and Management for Metabolic Side Effects of Antipsychotics
NCT01875861 ·Status: COMPLETED ·Phase: NA
-
Point-of-Care Testing (POCT) Detection and Management of Metabolic Syndrome in Patients With Mental Illness
NCT02029989 ·Status: COMPLETED ·Phase: NA
-
App and Body Fat Scale in the Management of Overweight Patients
NCT05866107 ·Status: RECRUITING ·Phase: NA
-
Northern Manhattan Study of Metabolism and Mind
NCT02470260 ·Status: ACTIVE_NOT_RECRUITING
-
Does Abnormal Insulin Action in the Brain Underlie Cognitive and Metabolic Dysfunction in Schizophrenia
NCT05748990 ·Status: RECRUITING ·Phase: NA
-
Effect of Atypical Antipsychotic Drugs Olanzapine and Amisulpride on Glucose Metabolism
NCT01160991 ·Status: COMPLETED ·Phase: NA
-
Healthy Lifestyles for Mentally Ill People Who Have Experienced Weight Gain From Their Antipsychotic Medications - 2
NCT01052714 ·Status: COMPLETED ·Phase: NA
-
Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients
NCT07045142 ·Status: RECRUITING ·Phase: PHASE3